ENTRY       D10106                      Drug
NAME        Dalantercept (USAN)
FORMULA     H3206H4960N904O976S38
EXACT_MASS  37714.6535
MOL_WEIGHT  37726.7792
SEQUENCE    DPVKPSRGPL VTCTCESPHC KGPTCRGAWC TVVLVREEGR HPQEERGCGN LHRELCRGRP
            TEFVNHYCCD SHLCNHNVSL VLEATQPPSE QPGTDGQLAT GGGTHTCPPC PAPEALGAPS
            VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST
            YRVVSVLTVL HQDWLNGKEY KCKVSNKALP VPIEKTISKA KGQPREPQVY TLPPSREEMT
            KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGPFFLYSK LTVDKSRWQQ
            GNVFSCSVMH EALHNHYTQK SLSLSPGK
            (Disulfide bridge: 13-30, 15-20, 25-48, 56-68, 69-74, 107-107', 110-110', 1442-202, 248-306, 13'-30', 15'-20', 25'-48', 56'-68', 69'-74', 142'-202', 248'-306')
  TYPE      Peptide
EFFICACY    Antineoplastic, Angiogenesis inhibitor
COMMENT     ALK1-Fc fusion protein
TARGET      ACVRL1 [HSA:94] [KO:K13594]
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor serine/threonine kinases (RSTK)
               TGFBR1 family
                ACVRL1
                 D10106  Dalantercept (USAN)
DBLINKS     CAS: 1186210-24-1
            PubChem: 135626824
///
